Oliver Gaemperli

Showing 1-5 of 5 articles

Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry

Sürder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger R, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G

June 12, 2020 | 10.4244/EIJ-D-19-00718

Interventions for valvular disease

First-in-man report of residual “intra-clip” regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II

Taramasso M, Zuber M, Gruner C, Gaemperli O, Nietlispach F, Maisano F

April 20, 2016 | 10.4244/EIJY14M12_04

Interventions for valvular disease

Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation

Frangieh A, Gruner C, Mikulicic F, Attinger-Toller A, Tanner F, Taramasso M, Corti R, Grünenfelder J, Lüscher T, Ruschitzka F, Bettex D, Maisano F, Gaemperli O

April 8, 2016 | 10.4244/EIJV11I14A320

Successful first-in-man Melody transcatheter valve implant in a dehisced mitral annuloplasty ring transapical valve-in-ring implant

Maisano F, Reser D, Pavicevic J, Nietlispach F, Gaemperli O, Schmid M, Bettex D, Falk V

December 22, 2014 | 10.4244/EIJV10I8A163

Integrated x-ray and echocardiography imaging for structural heart interventions

Corti R, Biaggi P, Gaemperli O, Bühler I, Felix C, Bettex D, Kretschmar O, Falk V, Grünenfelder J

November 29, 2013 | 10.4244/EIJV9I7A140

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Joint EAPCI/ACVC expert consensus document on pVADs

Beyond ischaemia: is there a place for physiologic and anatomic evaluations of coronary lesions?

Gilles Montalescot

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease